Eric Castaldi

Chief Financial Officer & Principal Accounting Officer at argenx SE

Eric Castaldi

Eric Castaldi

Chief Financial Officer & Principal Accounting Officer at argenx SE

Overview
Career Highlights

argenx SE
NicOx SA
MY Kinda Town Group Ltd.

RelSci Relationships

182

Number of Boards

3

Birthday

1965

Age

53

Relationships
RelSci Relationships are individuals Eric Castaldi likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer & Executive Director at argenx SE

Relationship likelihood: Strong

Chief Executive Officer at Evotec AG

Relationship likelihood: Strong

Inbiomotion SL

Relationship likelihood: Strong

President at Innovent LLC

Relationship likelihood: Strong

Executive Partner at Mpm Capital LLC

Relationship likelihood: Strong

Former Chief Medical Officer at Intellikine LLC

Relationship likelihood: Strong

Managing Partner & Co-Owner at LSP Management Group BV

Relationship likelihood: Strong

Chief Development Officer at argenx SE

Relationship likelihood: Strong

Chief Operating Officer at argenx SE

Relationship likelihood: Strong

General Counsel at argenx SE

Relationship likelihood: Strong

Paths to Eric Castaldi
Potential Connections via
Relationship Science
You
Eric Castaldi
Chief Financial Officer & Principal Accounting Officer at argenx SE
Education
Finance, Accountancy & Administration Graduate
Class of 1986

University of Nice Sophia Antipolis is a school in Nice.

Career History
Chief Financial Officer & Principal Accounting Officer
2014 - Current

argenx SE is a clinical-stage biotechnology company, which engages in the research and development of human monoclonal antibodies for the treatment of cancer and oncological, autoimmune, and inflammatory diseases. Its products include ARGX-113 for severe autoimmune diseases and ARGX-110 for T-cell lymphoma and acute myeloid leukemia. It operates through the following geographical segments: Netherlands, Belgium, Germany, Denmark, Switzerland, United States, and Luxemburg. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren on April 25, 2008 and is headquartered in Breda, the Netherlands.

Chief Financial Officer
1998 - Prior

Nicox SA is an ophthalmology company, which engages in developing innovative solutions to help maintain vision and improve ocular health. Its products include Zerviate, and Vyzulta. The company was founded by Piero Del Soldato, Michele Garufi and Elizabeth Marie Robinson on February 15, 1996 and is headquartered in Sophia-Antipolis, France.

Chief Operating Officer & Chief Financial Officer
1989 - 1997
Boards & Committees
Director
Prior - 2012

Hybrigenics SA operates as a biopharmaceutical company, which engages in the research and development of targets and therapies against proliferative diseases. It develops inecalcitol for the treatment of prostate cancer, chronic lymphocytic leukemia, and chronic myeloid leukemia. The company was founded on December 29, 1997 and is headquartered in Paris, France.

Director
2008 - 2012

Part of Hybrigenics SA, Hybrigenics Services SASU is a French company located in Paris. The firm develops and distributes screening assays for protein interactions mapping services. Etienne Formstecher has been the CEO since 2010.

Member, Executive Committee
Prior

Nicox SA is an ophthalmology company, which engages in developing innovative solutions to help maintain vision and improve ocular health. Its products include Zerviate, and Vyzulta. The company was founded by Piero Del Soldato, Michele Garufi and Elizabeth Marie Robinson on February 15, 1996 and is headquartered in Sophia-Antipolis, France.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Eric Castaldi. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Eric Castaldi's profile does not indicate a business or promotional relationship of any kind between RelSci and Eric Castaldi.